ArticleEndocrine, metabolic & immune disorders drug targets2026
Analysis of Necroptosis-Related Genes and Immune Cell Infiltration in Infantile Hemangioma.
Article in Endocrine, metabolic & immune disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionInfantile hemangioma (IH) is the most prevalent benign tumor in neonates, yet the role of necroptosis in its pathogenesis remains underexplored. This study aimed to investigate necroptosis-related gene expression patterns in IH, identify critical biomarkers, and develop a diagnostic model to enhance precision medicine approaches.
methodsGene expression data from GSE127487 and GSE100682 datasets were analyzed to screen necroptosis-related differentially expressed genes (NRDEGs). A diagnostic model was constructed using a support vector machine (SVM) and least absolute shrinkage and selection operator (LASSO) regression. Model validity was assessed via receiver operating characteristic (ROC) curve analysis. mRNA interaction networks and immune cell associations were explored using MCPCounter algorithms and single-sample gene set enrichment analysis.
resultsSeventy-four NRDEGs were identified, with six key genes highlighted. Network analysis revealed six miRNAs and 47 transcription factors associated with these genes. Additionally, six key genes showed associations with eight distinct immune cell types, suggesting potential roles in regulating the immune microenvironment. DISCUSSION: In this study, bioinformatics was employed to analyze data, construct diagnostic models, and identify key genes.
conclusionThe six key genes may serve as reliable biomarkers for IH, offering insights into precise diagnosis and personalized therapeutic strategies. This study advances understanding of necroptosis mechanisms in IH and their interplay with immune cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.